ATH alterity therapeutics limited

Below is an article posted by Doherty Institute where Dr....

  1. 3,119 Posts.
    lightbulb Created with Sketch. 1160

    Below is an article posted by Doherty Institute where Dr. Neville is studying how to treat antibiotic-resistant otitis median by zinc chelator. PBT2 is not mentioned but we know that the drug is PBT2.

    "Through her team’s work, Dr Neville has shown that the human body uses high concentrations of metal ions, such as zinc, to intoxicate invading bacteria.“Interestingly, when we therapeutically enhance this metal ion intoxication, we see that many bacterial species become resensitised to antibiotics that they were previously resistant to,” said Dr Neville.

    Click here to read more:

    https://www.doherty.edu.au/news-events/news/a-microbiologists-legacy-safeguarding-antibiotics-to-protect-children
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $119.6M
Open High Low Value Volume
1.1¢ 1.1¢ 1.0¢ $46.86K 4.283M

Buyers (Bids)

No. Vol. Price($)
64 25268416 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 18128695 9
View Market Depth
Last trade - 16.10pm 19/09/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.